home / stock / akao / akao news

AKAO News and Press, Achaogen From 03/28/19

Stock Information
Company Name: Achaogen
Stock Symbol: AKAO
Market: NASDAQ
Website: achaogen.com
Menu
AKAO AKAO Quote AKAO Short AKAO News AKAO Articles AKAO Message Board
Get AKAO Alerts

News, Short Squeeze, Breakout and More Instantly...
AKAO - Achaogen Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

-- ZEMDRI’s once-daily 30-minute infusion facilitating usage in the outpatient setting -- -- Company’s recent restructuring aimed at conserving capital to continue assessment of strategic alternatives -- -- Conference call today at 4:30 p.m. Eastern Time -- SOUTH S...
AKAO - Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2018 Financial Results on March 28, 2019

SOUTH SAN FRANCISCO, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today announced that it will...

AKAO - Achaogen (AKAO) Investor Presentation - Slideshow

The following slide deck was published by Achaogen, Inc. in conjunction with this Read more ...

AKAO - Achaogen (AKAO) To Present At SVB Leerink 8th Global Healthcare Conference - Slideshow

The following slide deck was published by Achaogen in conjunction with this Read more ...

AKAO - Achaogen's Last Capital Raise Signals Desperation

Last Friday, February 15, Achaogen ( AKAO ) announced a public offering of 15 million shares of common stock at the price of $1.00/share. In addition, each share was accompanied by one short-term warrant to purchase a share of common stock and one long-term warrant to purchase a share of com...

AKAO - Achaogen's ZEMDRI phase 3 study results published in the New England Journal of Medicine

Achaogen (NASDAQ: AKAO ) announces  that the New England Journal of Medicine has published the results from the Phase 3 EPIC (Evaluating Plazomicin In cUTI) study of ZEMDRI. More news on: Achaogen, Healthcare stocks news, Read more ...

AKAO - Achaogen Announces Closing of $15 Million Underwritten Public Offering

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today announced the completion...
AKAO - Achaogen Announces Presentations at Two Upcoming Investor Healthcare Conferences

-- Leerink February 27, 2019 at 9:30 a.m. ET -- -- Cowen March 12, 2019 at 12:00 p.m. ET -- SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial...

AKAO - Midday movers and shakers

Gainers:  Optical Cable (NASDAQ: OCC ) +29% . TriNet Group (NYSE: TNET ) +25% . Conformis (NASDAQ: CFMS ) +23% . Talend S.A. (NASDAQ: TLND ) +23% . SAExploration Holdings (NASDAQ: SAEX ) +21% . BioSig Technologies (NASDAQ: BSGM ) +19% . Blink Charging (NASDAQ: BLNK ) +18% . Adu...

AKAO - NWL, AKAO and XPO among premarket losers

Achaogen (NASDAQ: AKAO )  -37%  on pricing stock and warrant offering. More news on: Achaogen, Marin Software, TrueCar, Inc, Stocks on the move, Read more ...

Previous 10 Next 10